Le laboratoire est détenteur de 3 brevets :

• Le Garrec R, L’herondelle K, Misery L, Pierre O, Mignen O (2019) : Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxin poisoning. EP19 305 453.3
• Ben-Ari Y, Lemonnier E (2010) : Compounds for the treatment of autism. PCT/EP2011/050394
• Ben-Ari Y, Lemonnier E, Burnashev N, Tyzio R (2012) : Modulators of intracellular chloride concentration for treating fragile X syndrome. PCT/EP2013/073942